{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:35:07Z","timestamp":1791300907771,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.biopsych.2009.04.025","type":"journal-article","created":{"date-parts":[[2009,6,12]],"date-time":"2009-06-12T07:30:15Z","timestamp":1244791815000},"page":"603-613","source":"Crossref","is-referenced-by-count":238,"title":["Genetic Inactivation of Dopamine D1 but Not D2 Receptors Inhibits L-DOPA\u2013Induced Dyskinesia and Histone Activation"],"prefix":"10.1016","volume":"66","author":[{"given":"Sanja","family":"Darmopil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana B.","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene Ruiz","family":"De Diego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Moratalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2009.04.025_bib1","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1212\/WNL.51.2_Suppl_2.S30","article-title":"Neostriatal mechanisms in Parkinson's disease","volume":"51","author":"Chase","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2009.04.025_bib2","doi-asserted-by":"crossref","first-page":"7007","DOI":"10.1523\/JNEUROSCI.0676-04.2004","article-title":"Persistent increase in olfactory type G-protein alpha subunit levels may underlie D1 receptor functional hypersensitivity in Parkinson's disease","volume":"24","author":"Corvol","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2009.04.025_bib3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.biopsych.2005.05.044","article-title":"ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice","volume":"59","author":"Pavon","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2009.04.025_bib4","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.1523\/JNEUROSCI.0852-07.2007","article-title":"Critical involvement of cAMP\/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia","volume":"27","author":"Santini","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2009.04.025_bib5","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/j.1742-4658.2008.06296.x","article-title":"Parkinson's disease: Levodopa-induced dyskinesia and signal transduction","volume":"275","author":"Santini","year":"2008","journal-title":"FEBS J"},{"key":"10.1016\/j.biopsych.2009.04.025_bib6","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.nbd.2005.04.001","article-title":"Denervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: Implication of a dopamine D1-dependent mechanism","volume":"20","author":"St-Hilaire","year":"2005","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.biopsych.2009.04.025_bib7","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.biopsych.2006.11.032","article-title":"Spatiotemporal pattern of striatal ERK1\/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors","volume":"62","author":"Westin","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2009.04.025_bib8","first-page":"S160","article-title":"Clinical pharmacology of levodopa-induced dyskinesia","volume":"47","author":"Nutt","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2009.04.025_bib9","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/syn.20527","article-title":"Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat","volume":"62","author":"Carta","year":"2008","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2009.04.025_bib10","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.bbr.2003.10.009","article-title":"Behavioral sensitization to different dopamine agonists in a parkinsonian rodent model of drug-induced dyskinesias","volume":"152","author":"Delfino","year":"2004","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.biopsych.2009.04.025_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.nbd.2007.03.013","article-title":"Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson's disease","volume":"27","author":"Ding","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.biopsych.2009.04.025_bib12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.brainresbull.2004.10.011","article-title":"Validation of the L-DOPA-induced dyskinesia in the 6-OHDA model and evaluation of the effects of selective dopamine receptor agonists and antagonists","volume":"68","author":"Monville","year":"2005","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.biopsych.2009.04.025_bib13","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.pbb.2005.06.013","article-title":"Dopamine D1 and D2 receptor contributions to L-DOPA-induced dyskinesia in the dopamine-depleted rat","volume":"81","author":"Taylor","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.biopsych.2009.04.025_bib14","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1471-4159.2008.05831.x","article-title":"L-DOPA activates ERK signaling and phosphorylates histone H3 in the striatonigral medium spiny neurons of hemiparkinsonian mice","volume":"108","author":"Santini","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.biopsych.2009.04.025_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cercor\/bhm026","article-title":"D1 but not D5 dopamine receptors are critical for LTP, spatial learning, and LTP-induced arc and zif268 expression in the hippocampus","volume":"18","author":"Granado","year":"2008","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.biopsych.2009.04.025_bib16","doi-asserted-by":"crossref","first-page":"8506","DOI":"10.1523\/JNEUROSCI.23-24-08506.2003","article-title":"Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity","volume":"23","author":"Centonze","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2009.04.025_bib17","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.clinthera.2006.08.004","article-title":"A review of the receptor-binding and pharmacokinetic properties of dopamine agonists","volume":"28","author":"Kvernmo","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.biopsych.2009.04.025_bib18","doi-asserted-by":"crossref","first-page":"27925","DOI":"10.1016\/S0021-9258(18)46876-7","article-title":"High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype","volume":"269","author":"Tiberi","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopsych.2009.04.025_bib19","doi-asserted-by":"crossref","first-page":"14928","DOI":"10.1073\/pnas.93.25.14928","article-title":"Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor","volume":"93","author":"Moratalla","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2009.04.025_bib20","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0092-8674(94)90557-6","article-title":"Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses","volume":"79","author":"Xu","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.biopsych.2009.04.025_bib21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0896-6273(00)80351-7","article-title":"Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice","volume":"19","author":"Kelly","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.biopsych.2009.04.025_bib22","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1601-183X.2008.00392.x","article-title":"Role of dopamine D1-like receptors in methamphetamine locomotor responses of D2 receptor knockout mice","volume":"7","author":"Kelly","year":"2008","journal-title":"Genes Brain Behav"},{"key":"10.1016\/j.biopsych.2009.04.025_bib23","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0306-4522(00)00223-2","article-title":"The indirect basal ganglia pathway in dopamine D(2) receptor-deficient mice","volume":"99","author":"Murer","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2009.04.025_bib24","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1460-9568.2008.06040.x","article-title":"Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA","volume":"27","author":"Darmopil","year":"2008","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2009.04.025_bib25","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.biopsych.2003.08.008","article-title":"Chronic treatment with atypical neuroleptics induces striosomal FosB\/DeltaFosB expression in rats","volume":"55","author":"Grande","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2009.04.025_bib26","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1046\/j.1460-9568.2002.02280.x","article-title":"Molecular phenotype of rat striatal neurons expressing the dopamine D5 receptor subtype","volume":"16","author":"Rivera","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2009.04.025_bib27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF01187858","article-title":"Distribution of enkephalin-immunoreactive nerve fibres and terminals in the region of the nucleus basalis magnocellularis of the rat: A light and electron microscopic study","volume":"17","author":"Martinez-Murillo","year":"1988","journal-title":"J Neurocytol"},{"key":"10.1016\/j.biopsych.2009.04.025_bib28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/syn.20466","article-title":"Early loss of dopaminergic terminals in striosomes after MDMA administration to mice","volume":"62","author":"Granado","year":"2008","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2009.04.025_bib29","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.nbd.2004.01.007","article-title":"A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: Relation to motor and cellular parameters of nigrostriatal function","volume":"16","author":"Lundblad","year":"2004","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.biopsych.2009.04.025_bib30","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1471-4159.2008.05417.x","article-title":"Striatal histone modifications in models of levodopa-induced dyskinesia","volume":"106","author":"Nicholas","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.biopsych.2009.04.025_bib31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0306-4522(02)00548-1","article-title":"Effects of oligonucleotide antisense to dopamine D3 receptor mRNA in a rodent model of behavioural sensitization to levodopa","volume":"116","author":"van Kampen","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2009.04.025_bib32","first-page":"103","article-title":"DOPA-induced \u201cpeak dose\u201d dyskinesia: Clues implicating D2 receptor-mediated mechanisms using dopaminergic agonists in MPTP monkeys","volume":"45","author":"Blanchet","year":"1995","journal-title":"J Neural Transm Supplementum"},{"key":"10.1016\/j.biopsych.2009.04.025_bib33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0197-0186(99)00064-9","article-title":"Chronic D1 and D2 dopaminomimetic treatment of MPTP-denervated monkeys: Effects on basal ganglia GABA(A)\/benzodiazepine receptor complex and GABA content","volume":"35","author":"Calon","year":"1999","journal-title":"Neurochem Int"},{"key":"10.1016\/j.biopsych.2009.04.025_bib34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0006-8993(96)00157-6","article-title":"Dyskinesias and tolerance induced by chronic treatment with a D1 agonist administered in pulsatile or continuous mode do not correlate with changes of putaminal D1 receptors in drug-naive MPTP monkeys","volume":"719","author":"Goulet","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2009.04.025_bib35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/archneur.58.2.249","article-title":"Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson's disease","volume":"58","author":"Rascol","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biopsych.2009.04.025_bib36","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/350614a0","article-title":"Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1","volume":"350","author":"Sunahara","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2009.04.025_bib37","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1755-5949.2008.00047.x","article-title":"A review of the discovery, pharmacological characterization, and behavioral effects of the dopamine D2-like receptor antagonist eticlopride","volume":"14","author":"Martelle","year":"2008","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.biopsych.2009.04.025_bib38","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00213-003-1770-x","article-title":"The role of dopamine D3 compared with D2 receptors in the control of locomotor activity: A combined behavioural and neurochemical analysis with novel, selective antagonists in rats","volume":"174","author":"Millan","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2009.04.025_bib39","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1124\/jpet.102.039875","article-title":"Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor","volume":"303","author":"Newman-Tancredi","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2009.04.025_bib40","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1073\/pnas.94.7.3363","article-title":"Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa","volume":"94","author":"Bordet","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2009.04.025_bib41","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.expneurol.2005.02.002","article-title":"Pharmacological validation of a mouse model of L-DOPA-induced dyskinesia","volume":"194","author":"Lundblad","year":"2005","journal-title":"Exp Neurol"},{"key":"10.1016\/j.biopsych.2009.04.025_bib42","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/mds.870130207","article-title":"De novo administration of ropinirole and bromocriptine induces less dyskinesia than L-DOPA in the MPTP-treated marmoset","volume":"13","author":"Pearce","year":"1998","journal-title":"Mov Disord"},{"key":"10.1016\/j.biopsych.2009.04.025_bib43","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1523\/JNEUROSCI.18-09-03470.1998","article-title":"Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations","volume":"18","author":"Kelly","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2009.04.025_bib44","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1006\/nbdi.1999.0259","article-title":"Striatal fosB expression is causally linked with L-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease","volume":"6","author":"Andersson","year":"1999","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.biopsych.2009.04.025_bib45","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/ana.410420508","article-title":"Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesias","volume":"42","author":"Piccini","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2009.04.025_bib46","first-page":"41","article-title":"Opioid peptide precursor expression in animal models of dystonia secondary to dopamine-replacement therapy in Parkinson's disease","volume":"78","author":"Brotchie","year":"1998","journal-title":"Adv Neurol"},{"key":"10.1016\/j.biopsych.2009.04.025_bib47","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s002210050545","article-title":"Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior","volume":"123","author":"Steiner","year":"1998","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.biopsych.2009.04.025_bib48","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.neuroscience.2008.09.019","article-title":"Additive effects of histone deacetylase inhibitors and amphetamine on histone H4 acetylation, cAMP responsive element binding protein phosphorylation and DeltaFosB expression in the striatum and locomotor sensitization in mice","volume":"157","author":"Shen","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2009.04.025_bib49","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nrn2132","article-title":"Epigenetic regulation in psychiatric disorders","volume":"8","author":"Tsankova","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.biopsych.2009.04.025_bib50","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1124\/jpet.107.126219","article-title":"Evaluation of levodopa dose and magnitude of dopamine depletion as risk factors for levodopa-induced dyskinesia in a rat model of Parkinson's disease","volume":"323","author":"Putterman","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2009.04.025_bib51","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/brain\/awn305","article-title":"Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration","volume":"132","author":"Carlsson","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.biopsych.2009.04.025_bib52","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/brain\/awm082","article-title":"Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats","volume":"130","author":"Carta","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.biopsych.2009.04.025_bib53","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0079-6123(08)00922-9","article-title":"Serotonin-dopamine interaction in the induction and maintenance of L-DOPA-induced dyskinesias","volume":"172","author":"Carta","year":"2008","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.biopsych.2009.04.025_bib54","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/nrn2471","article-title":"Molecular mechanisms of L-DOPA-induced dyskinesia","volume":"9","author":"Jenner","year":"2008","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.biopsych.2009.04.025_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2008.09.013","article-title":"Priming for L-DOPA-induced dyskinesia in Parkinson's disease: A feature inherent to the treatment or the disease?","volume":"87","author":"Nadjar","year":"2009","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.biopsych.2009.04.025_bib56","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/(SICI)1096-9861(19961007)374:1<70::AID-CNE5>3.0.CO;2-K","article-title":"Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum","volume":"374","author":"Hiroi","year":"1996","journal-title":"J Comp Neurol"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322309005095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322309005095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T04:33:14Z","timestamp":1633581194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322309005095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0006322309005095"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2009.04.025","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}